CVKD Q1 2026 Earnings Narrower Loss Surprises Clinical Progress Maintained CCG Q4 2024 Earnings Narrowerthanexpected loss drives positive surprise despite stock decline EHTH Q1 2026 Earnings EPS Misses Estimates Sharply as Losses Deepen CL Q1 2026 Earnings Slight EPS Miss Amid Steady Performance IIIN Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Conditions Design Therapeutics DSGN Edges Higher as Support Holds Above 1060 MetLife Inc MET Holds Steady Near 84 as Broader Market Volatility Persists TKO Group Holdings TKO Holds Steady Near Resistance Amid Low Volatility Tarsus Pharmaceuticals TARS Shows Resilience Near Support After Moderate Decline PZG Q1 2026 Earnings Significant EPS Miss Reflects PreRevenue Exploration Stage HTH Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline AIRG Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction CWT Q1 2026 Earnings Earnings Miss Amidst Operational Challenges Stock Still Rises CLBK Q1 2026 Earnings EPS Misses Estimates by 178 Amid Challenging Environment Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress PRHI Q1 2024 Earnings Significant EPS Beat Fails to Impress Markets APTV Q1 2026 Earnings EPS Surges Past Estimates as Operational Discipline Drives Beat